BETA-GLUCURONID-LINKER-ARZNEIKONJUGATE

European patent · EP1912671 · Deleted

Register entry

Publication number
EP1912671
Application number
EP06787774
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 18, 2006
Published
Apr 23, 2008
Granted
Sep 6, 2017
Deleted
Feb 24, 2026
Reason
Annual fee unpaid
IPC classes
A61K 39/00 (2006.01)
C07K 16/00 (2006.01)
Priority
US 700422 P 18.07.2005
US 779076 P 04.03.2006
PCT application
PCT/US2006/027925 18.07.2006
PCT publication
WO2007/011968 25.01.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 24, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.02.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.02.2026

  2. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  3. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  4. Aug 8, 2022

    Change

    Published in Swissreg on 08.08.2022

  5. Jun 1, 2021

    Address changed

    Owner
    Seattle Genetics, Inc., 21823 30th Drive, S.E., Bothell, WA 98021, USA → Seagen Inc., 21823 30th Drive, S.E., Bothell, WA 98021, USA

    Published in Swissreg on 01.06.2021

  6. Sep 6, 2017

    Granted

    Published in Swissreg on 06.09.2017

Parties

Holder

SEAGEN INC.

Seagen Inc.

21823 30th Drive, S.E., Bothell, WA 98021, US

Inventor

JEFFREY, Scott

Snohomish, WA 98296, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.